IL-10 production in multiple sclerosis patients, SLE patients and healthy controls: Preliminary findings

M. Gelati; E. Lamperti; A. Dufour; E. Corsini; E. Venegoni; C. Milanese; A. Nespolo; A. Salmaggi

doi:10.1007/BF02080463

IL-10 production in multiple sclerosis patients, SLE patients and healthy controls: Preliminary findings

M. Gelati, E. Lamperti, A. Dufour, E. Corsini, E. Venegoni, C. Milanese, A. Nespolo, A. Salmaggi

Research output: Contribution to journal › Article › peer-review

Abstract

IL-10 is a cytokine with suppressive effects on (auto) antigen presentation and T-cell-mediated immune reactions, but is also capable of stimulating polyclonal IgG synthesis. Recent evidence suggests its involvement in multiple sclerosis (MS) and systemic lupus erythematosus (SLE). We assessed PBMNC IL-10 release in MS and SLE patients before and after in vivo prednisone or methylprednisolone treatment. The SLE patients showed a high level of IL-10 release by unstimulated PBMNCs, whereas the PHA- stimulated PBMNCs from MS patients produced large amounts of the cytokine.

Original language	English
Pages (from-to)	191-194
Number of pages	4
Journal	Italian Journal of Neurological Sciences
Volume	18
Issue number	4
DOIs	https://doi.org/10.1007/BF02080463
Publication status	Published - 1997

Keywords

IL-10
SLE
SM
Steroids

ASJC Scopus subject areas

Neuroscience(all)
Clinical Neurology
Psychiatry and Mental health
Dermatology

Access to Document

10.1007/BF02080463

Fingerprint Dive into the research topics of 'IL-10 production in multiple sclerosis patients, SLE patients and healthy controls: Preliminary findings'. Together they form a unique fingerprint.

Cite this

@article{01053180de4e4a8bb62c51b61a1b92ac,

title = "IL-10 production in multiple sclerosis patients, SLE patients and healthy controls: Preliminary findings",

abstract = "IL-10 is a cytokine with suppressive effects on (auto) antigen presentation and T-cell-mediated immune reactions, but is also capable of stimulating polyclonal IgG synthesis. Recent evidence suggests its involvement in multiple sclerosis (MS) and systemic lupus erythematosus (SLE). We assessed PBMNC IL-10 release in MS and SLE patients before and after in vivo prednisone or methylprednisolone treatment. The SLE patients showed a high level of IL-10 release by unstimulated PBMNCs, whereas the PHA- stimulated PBMNCs from MS patients produced large amounts of the cytokine.",

keywords = "IL-10, SLE, SM, Steroids",

author = "M. Gelati and E. Lamperti and A. Dufour and E. Corsini and E. Venegoni and C. Milanese and A. Nespolo and A. Salmaggi",

year = "1997",

doi = "10.1007/BF02080463",

language = "English",

volume = "18",

pages = "191--194",

journal = "Italian Journal of Neurological Sciences",

issn = "0392-0461",

publisher = "Springer Verlag",

number = "4",

}

TY - JOUR

T1 - IL-10 production in multiple sclerosis patients, SLE patients and healthy controls

T2 - Preliminary findings

AU - Gelati, M.

AU - Lamperti, E.

AU - Dufour, A.

AU - Corsini, E.

AU - Venegoni, E.

AU - Milanese, C.

AU - Nespolo, A.

AU - Salmaggi, A.

PY - 1997

Y1 - 1997

N2 - IL-10 is a cytokine with suppressive effects on (auto) antigen presentation and T-cell-mediated immune reactions, but is also capable of stimulating polyclonal IgG synthesis. Recent evidence suggests its involvement in multiple sclerosis (MS) and systemic lupus erythematosus (SLE). We assessed PBMNC IL-10 release in MS and SLE patients before and after in vivo prednisone or methylprednisolone treatment. The SLE patients showed a high level of IL-10 release by unstimulated PBMNCs, whereas the PHA- stimulated PBMNCs from MS patients produced large amounts of the cytokine.

AB - IL-10 is a cytokine with suppressive effects on (auto) antigen presentation and T-cell-mediated immune reactions, but is also capable of stimulating polyclonal IgG synthesis. Recent evidence suggests its involvement in multiple sclerosis (MS) and systemic lupus erythematosus (SLE). We assessed PBMNC IL-10 release in MS and SLE patients before and after in vivo prednisone or methylprednisolone treatment. The SLE patients showed a high level of IL-10 release by unstimulated PBMNCs, whereas the PHA- stimulated PBMNCs from MS patients produced large amounts of the cytokine.

KW - IL-10

KW - SLE

KW - SM

KW - Steroids

UR - http://www.scopus.com/inward/record.url?scp=0030967735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030967735&partnerID=8YFLogxK

U2 - 10.1007/BF02080463

DO - 10.1007/BF02080463

M3 - Article

C2 - 9323512

AN - SCOPUS:0030967735

VL - 18

SP - 191

EP - 194

JO - Italian Journal of Neurological Sciences

JF - Italian Journal of Neurological Sciences

SN - 0392-0461

IS - 4

ER -

IL-10 production in multiple sclerosis patients, SLE patients and healthy controls: Preliminary findings

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this